chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, fever of 102.2 for five days. Saw PCP on 11/04/2009 and was checked for strep throat with results being negative in the office. Pt also had a very deep cough and non-productive with extreme fatigue and body aches.  Medical records received for DOS 11/4/09. PCP Office notes. Final DX. Viral illness, cough, pharyngitis. C/O cough, sore throat, no appetite, fever  102.3. Three days s/p Flumist. Neg Strep A. Supportive care.
Patient developed a red rash that was slightly warm to the touch from just above his elbow to just above his injection site a few hours after receiving the Moderna bivalent booster. No other symptoms noted. The rash has greatly improved now, 5 days after the injection.
No additional AE; TE case; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided.   On 21-JUL-2023, the patient was vaccinated with the second dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, subcutaneously, lot number x006983 with expiration date 07-MAR-2025 (dosage regimen was not reported). The vaccine had undergone a temperature excursion (TE) at a temperature of -12.48 degrees Celsius for 1 hour and 30 minutes with 0 seconds, there were no previous temperature excursions (Product storage error). No additional adverse events were reported (No adverse event).
patient had flu all 4 times; Initial information received on 08-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involved a patient with unknown demographics who had flu all 4 times (influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had 4 flu shots while working (no choice) and had flu all 4 times (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
On April 8, 2021, I received the J&J vaccine. Initially, I only had the chills and body aches. Then, on Monday April 12, 2021, I went to the gym where I worked out. When I came home and after showering, I returned a phone call shortly after 8 P.M. While speaking on the phone, I could tell after a few minutes of talking something was off, and then all of a sudden, the words stopped coming out. After a few more seconds, I was trying to yell upstairs to my wife for help. I sounded like a goat while trying to yell that word. I then snapped out of it, and was able to speak clearly and normal again. I told my wife and called back my friend. My friend said I sounded like I was getting sick when I had the attack. The next morning I went to the hospital. I was diagnosed with a Transient Ischemic Attack "TIA."
Started about two weeks after last vaccination shot. Left hand palm red and itchy, spread to right hand as same, and then to other parts of the body as hives, very itchy hives across whole body. Seems to be some kind of allergic reaction, though do not have any allergies that I am aware of currently.
Weakness; Chills; Achiness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weakness), CHILLS (Chills), MYALGIA (Achiness) and NAUSEA (Nausea) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
/o fatigue, weakness around 1330. Beginning at 1700, caller c/o stomach cramps, diarrhea & nausea. Today, c/o intermittent mild cramps. Denies any other symptoms. Advised to increase fluids if possible, continue to take normal medications as prescibed. Follow up with PCP if you symptoms get worse, or UC/ER for severe symptoms
I26.99 ACUTE PULMONARY EMBOLISM 10/12/2022 ACUTE PULMONARY EMBOLISM I26.99 ACUTE PULMONARY EMBOLISM 10/12/2022 DM 2 W EYE MANIFESTATION I26.99 ACUTE PULMONARY EMBOLISM 10/12/2022 ANEMIA I26.99 ACUTE PULMONARY EMBOLISM 10/12/2022 DM 2 W EYE MANIFESTATION
On 15th of June I began throwing up, couldn't keep food down, major cramping in my stomach, wouldn't go away, chills that lasted until 6/24, I took peptol bispol, tums, ginger, but still cramped and threw up, couldn't eat, slept a lot because of pain.  I did stop taking the metrondasel antibotic given for my swallon jawl, kept taking Pennicillin because I'm not allergic.  I was very weak, on vacation when this started, couldn't be out in the side much at all, felt like I was going to pass out.  Later in week begin having tingling in my feet like they were going to sleep and in my upper legs/hips.  I do have stents in my legs that are doing well, so it kind of worried me that they were tingling.   On 24th of June, went to my doctor, she gave me Hyoscyamine for pain/discomfort in my stomach and back, also PureGG 25B for probiotic. It's been working ok, but still having stomach episodes of pain and goes to my back like sharp object. Also I've never had heartburn until this sickness, have to have tums and something for pain every once in a while, should've been over all of this by now, but have called the new doctor because I'm not sure what's going on.  I'm not a sickly person.
Approx. 5 minutes after receiving vaccine, pt complained of feeling faint, she then went limp & began to seize for about 10 seconds. Paramedics arrived, vitals were stable, pt declined hospitalization. Pt states this has happened in the past w/ blood work.
Arthritis, depression, joint pain, spots on the skin, imbalance, dizziness, erectile dysfunction, anxiety.
Pt developed redness around her left deltoid area that was red, warm to touch, no streaking. Doctor stated it was possible cellulitis. Started Cephalexin 500mg BID x10. Nurse administered Pneumovax23 in same arm as influenza vaccine in the afternoon after the influenza shot (Pharmacy) 9/29/2014. Severe pain which affected ADL's with left arm.
pulmonary embolism; Covid 19 PCR positive (Igg also positive) with chest x-ray consistent with Covid pneumonia, 2 weeks after 1st dose; Covid 19 PCR positive (Igg also positive) with chest x-ray consistent with Covid pneumonia, 2 weeks after 1st dose; This is a spontaneous report from a non-contactable other healthcare professional. An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was admitted with pulmonary embolism and Covid 19 PCR positive (Igg also positive) with chest x-ray consistent with Covid pneumonia, 2 weeks after the 1st dose of Pfizer vaccine. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information provided by the reporter, it appears unlikely that subject product contributed to the events. The reported events may likely represent intercurrent medical conditions.  Pulmonary embolism is known to be a potential complication of COVID 19 infection, including COVID 19 associated pneumonia.   There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including pulmonary angiogram, VQ scan and coagulation panel, counteractive treatment measures and concomitant medications.  This case will be reassessed upon receipt of follow-up information.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Widespread itching and urticaria (hives) on hands, feet, forearms, armpits, knees, scalp, neck, waistline, buttocks.  Severe worsening of GERD symptoms that prevent adequate sleep. Some initial research suggests treatment should include a combination of H1 and H2 blockers. Initially treated with Fexofenadine 180mg once daily, Famotidine 20mg twice daily, and topical Hydrocortizone 1% as needed. Marginal reduction in itchiness and hives with initial treatment, no significant reduction in GERD symptoms. Currently treating with Cetirizine 10mg once daily, Famotidine 20mg twice daily, and topical Hydrocortizone 1% as needed. Started current treatment today, outcome TBD.
Dx: Small bowel intussusception. Treatment: Reduced with an air enema. Signs/Symptoms: Went to hospital with vomiting.
Pt did not dilute Pfizer vaccine before administration. According to two Ladies she received 0.3mL of undiluted Pfizer vaccine.
hand still tingles; Elevated blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Elevated blood pressure) and PARAESTHESIA (hand still tingles) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Acid reflux (esophageal). Concomitant products included IRON for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (Elevated blood pressure). On an unknown date, the patient experienced PARAESTHESIA (hand still tingles). At the time of the report, BLOOD PRESSURE INCREASED (Elevated blood pressure) had resolved and PARAESTHESIA (hand still tingles) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Blood pressure measurement: 200 (High) Unknown and 210 (High) Unknown.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant medication included acid reflux medication.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received contains 1st dose information , new events were updated On 26-May-2021: follow up received  does not contain any new information.
PT DESCRIBED ITCHING AND START OF RASH AT INJECTION SITE ALMOST IMMEDIATELY UPON VACCINATION. ONE DOSE OF ORAL BENADRYL WAS GIVEN. PROGRESSION OF ALLERGY NOT WITNESSED DURING 30 MINUTE WAIT PERIOD. PT DID NOT PROGRESS TO MORE SEVERE ALLERGY
Received DTaP on 10/28/2014. 1 week later developed an urticarial rash with an elliptical erythema at site of DTaP and dryness surrounded by urticaria on leg. Between 11/13 and 11/28/2014 injection site no longer looked dry and the rash became less raised but continued to spread symmetrically to other leg, onto abdomen and onto arms. Consistent with an erythema multiforme rash but clearly has ablanching erythematous discoloration at the injection site. Mildy itchy if doesn't have pants on. No other symptoms. Otherwise acting fine.
Dry throat; chills; Very bad headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route administration in the left arm on 17Mar2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included unspecified vitamins (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 17Mar2021 at 15:30, the patient had experienced dry throat, chills, very bad headache and tiredness. It was unknown if therapeutic measures were taken for the events. Adverse events did not result in doctor or other healthcare professional office or clinic visits, emergency room or department, or urgent care. The clinical outcome of the events dry throat, chills, very bad headache and tiredness was unknown.   Information about lot/batch number cannot be obtained. No further information is expected
Information regarding PREVNAR was received from a consumer regarding a 3-month-old female patient who experienced low grade fever, fussy and did not have appetite.  At 3 months of age, the patient received a dose on 07-Feb-2008.  The patient's concurrent illness includes nasopharyngitis.  Product was administered on 07-Feb-2008.  Concomitant medications were not reported.  The patient experienced low grade fever, was fussy and did not have appetite on 07-Feb-2008.  Outcome of the events of pyrexia and irritability was unknown.  The patient was considered not recovered from the anorexia.  No additional information was available at the time of this report. Follow-up the patient recovered (2008).
Nurse reported after vaccination patient ?passed out? Patient appeared diaphoretic, pale, lethargic Patient was able to answer questions Patient seen by medical team, The blood pressure and heart rate low , patient provided with IV fluids, patient advised and agreed to go to hospital Patient was transferred to hospital via ambulance
23MAY91 vax given; 24MAY91 mom phoned clinic arm swollen twice size fr inject site to elbow-reported entire area also red & warm to touch; temp normal; Seen by MD tx DPH & cold compress to area; advised to with hold pertussis w/next immun;
FLUSHED; WATERING EYES; SUNBURN-LIKE RASH; CHILLS; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included copd from 911 exposure, asthma, chronic rhinitis, thyroiditis, lipidaemia, codeine allergy, and levaquin allergy. The patient experienced drug allergy when treated with betamethasone, ciprofloxacin, and bupivacaine hydrochloride/epinephrine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced flushed. On 10-APR-2021, the subject experienced watering eyes. On 10-APR-2021, the subject experienced sunburn-like rash. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced low grade fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flushed, and sunburn-like rash on 11-APR-2021, and watering eyes, chills, and low grade fever on 12-APR-2021. This report was non-serious.
I was sick with moderate flu-like symptoms for two days, then recovered from those. However, I am continuing to experience a major increase in my fibromyalgia/Chronic Fatigue Syndrome symptoms (excessive daytime drowsiness where I need at least a 4-hour nap each day with 7 hours sleep/night, and also full body muscle and joint pain that is not getting better with usual treatments of Lyrica, hot baths or heat pad, light activity, rest, or ibuprofen). My symptoms were being managed daily by those treatments to get down to a ?3 or 4-out-of-10 scale? level.  Since my second Pfizer vaccine I am averaging about  ?7-out-of-10 scale? pain, and unmanageable fatigue. I have never had any reactions to vaccines before and am fully vaccinated.
On January 31, 2017 He began running a high fever (102.8) that persisted even with alternating Motrin and Tylenol. February 1, 2017 Fever returned around 2:00 PM along with a few red sores around his mouth. February 2, 2017 He woke up with a severe rash on his face and left ear. He also had the red bumps beginning to appear behind his legs and on his arms.
PEDIATRIC VACCINE WAS USED INSTEAD OF PFIZER GREY TOP 12 & UP. VACCINE WAS NOT MIXED WITH SALINE PRIOR TO ADMINISTRATION
This spontaneous report was received from a pharmacist and healthcare worker refers to a patient of unknown demographics. The patient's medical history and concurrent conditions were not reported. On 12-JUN-2015 at 16:51, the patient was vaccinated with a dose of ZOSTAVAX (lot # K026365, expiration date: 15-MAR-2015, dose and anatomical location was unknown) which was exposed to temperature outside of the recommended range. Concomitant medications were unspecified by reporter. No adverse effect was observed or reported. The outcome of the events was unknown. Additional information has been requested.
No known adverse effects; patient received an expired dose of VAQTA; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On 29-MAY-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot # R010954, expiration date: 27-MAY-2019) intramuscularly (strength, dose and frequency were not reported) for prophylaxis (expired vaccine used). No unknown adverse effects.
Vaccine given at 1pm, pm started to get fatigue 1am chills, fever, malaise.
Brain fog started the day after the shot. Kind of like a headache, but more like dull pressure. Feels like I was drugged. I have a type of confusion that will not clear.  Trouble concentrating and I use the wrong words occasionally. It has remained the same severity, except 2 weekend was worse. Doesn't seem to be getting better. I am worried it will not dissipate.    Had depression the 2nd and 3rd day, that cleared up the 4th day was gone.
Information has been received from a physician concerning a 17 week patient who on 30-MAR-2007 was vaccinated with a second dose of ROTATEQ Lot # 656102/1165F). On 06-APR-2007, the patient was vaccinated with the third dose of oral ROTATEQ (lot # 656302/1165F). No further information was available.
Local reaction at injection site noted 5 days post vax site raised with erythema, no macules or papules noted. Rash around forehead not the extremities the trunk and lower legs.
Sore arm Rash on arm Bruising on palm of hand Severe headache Nausea Fatigue Body aches Sinus issues
Started having itchy palms, woke up with burning itchy rash around flank 03/21/2021 5 days after shot. Took Benadryl slept for awhile woke up with hives all over legs but. Took took more Benadryl. Went to urgent care 4:00 on March  dr. review my condition as acute hives. Prescribed cimetidine 300 mg, loratadine 10mg, methylprednisolone 4mg pack dose
Patient previously had an adverse reaction of throat tightness to the first dose of the Moderna covid vaccine. She had been counseled to discuss with her doctor about getting a second dose, and if cleared, to receive the second dose at a hospital facility. Patient reports that she discussed with her doctor, who advised her to wait for allergy testing, however the patient chose not to wait for the shipment and decided to proceed with receiving the second dose at the same location as the first dose.   Per patient, had taken two puffs of QVAR prior to second dose vaccination. 11:30am Time of administration of second dose 11:40am Adverse reaction began. Patient reports throat tightness, lightheadedness, foggy.  Denies trouble breathing, itching. Reports had breakfast. Two areas of erythema noted on her neck. No erythema on chest/trunk/arms/face/ears.   11:50pm BP 147/92, HR 91, O2 sat 99% 12:01pm Administered two tablets of 25mg diphenhydramine. 12:03pm  O2 sat 99%, HR 112. Appears teary-eyed, distressed about circumstances. Lungs clear to auscultation bilaterally, no stridor or use of accessory muscles.  12:08pm Neck erythema resolving.  12:11pm O2 sat 99%, HR 92, BP 143/97. Reports throat tightness feels the same, but not worse.  12:19pm O2 sat 99%, HR 94 12:28pm Reports throat still tight, but feeling much better. Affect and appearance much improved, no acute distress, lucid and conversational. No erythema on neck/chest/trunk/arms/face/ears.   12:35pm Patient declined offer to consider EMS if throat tightness not resolving. Patient has her own epi-pen. Provided counseling on s/s of anaphylaxis, training husband on use of epi-pen. Instructed to call 911 if symptoms worsen or have difficulty breathing.  12:45pm BP 145/88, HR 89, O2 sat 99% 12:49pm Discharged home.
Shot given at 1130 AM on 6/21/18. Symptoms started at 100 AM on 6/22/18, included fever, nausea and headache. Also soreness/warmth at injection site. Diagnosed with cellulitis and prescribed KEFLEX 500mg and ZOFRAN 4mg.
weakness; sweating at night; chills; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (weakness), HYPERHIDROSIS (sweating at night) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer on 21-Jan-2021, Pfizer on 11-Feb-2021 and Pfizer on 05-Oct-2021. Past adverse reactions to the above products included No adverse reaction with Pfizer, Pfizer and Pfizer.   On 31-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), HYPERHIDROSIS (sweating at night) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ASTHENIA (weakness), HYPERHIDROSIS (sweating at night) and CHILLS (chills) outcome was unknown.     No concomitant medications were reported. Patient received 4th dose of Moderna vaccine on 01-Jul-2022. After receiving Moderna Bivalent vaccine patient experienced chills, weakness and sweating at night. caller stated she was told that these side effects would be there for 2-3 days but its day 5.
Pt reports redness and itchiness near vaccination site which started night of vaccination; which is slowly getting better, but still present today (8 days later). Pt reports icing site and taking oral BENADRYL to aid with itchiness and redness.
VACCINE WAS EXPIRED, NO ADVERSE REACTION Other minors/patients received same vaccine On 10/30/20, called VAER 1800 # spoke to person to report these incidents.